Currently doctors rely on basic cognitive tests and conventional brain scans to diagnose dementia, but these are not able to recognise the disease at an early stage.

If a much wider range of markers can be identified which enable a better and earlier diagnosis, then doctors will have more time to delay the progression of the disease.

Return on investment: The project will reduce the costs of supporting people with dementia.